Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in infants, children, and
adolescents worldwide; however, despite sufficient evidence of the beneficial effects of …

Objectives: The disease caused by severe acute respiratory syndrome coronavirus 2, known
as coronavirus disease 2019, has resulted in a global pandemic. Reports are emerging of a …

Kawasaki disease (KD) is a common medium vessel systemic vasculitis that usually occurs
in small children. It has a predilection for the coronary arteries, but other medium sized …

Objective To provide evidence‐based recommendations and expert guidance for the
management of Kawasaki disease (KD), focusing on clinical scenarios more commonly …

Background A healthy 25-year-old woman developed COVID-19 disease with clinical
characteristics resembling Multisystem Inflammatory Syndrome in Children (MIS-C), a rare …

Introduction The epidemiology and clinical manifestations of severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) infection are different in children and adolescents …

Background Kawasaki disease (KD) is now the leading cause of acquired heart disease in
children in developed countries. Intravenous immunoglobulin (IVIG) and aspirin were …

Kawasaki disease is an acute childhood self-limited vasculitis, causing the swelling or
inflammation of medium-sized arteries, eventually leading to cardiovascular problems such …

Background and aims Few data are currently available for Kawasaki disease (KD) below 12
months especially in Caucasians. This study aims to analyze clinical and laboratory features …

Kawasaki disease (KD) is a vasculitis of unknown origin that predominates in infants. KD is
the most common cause of acquired cardiac disease in children because it causes cardiac …